Sifei Han
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Drug Transport and Resistance Mechanisms
Papers in
-
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 3
- Oncology 12
- Drug Transport and Resistance Mechanisms 7
- Lymphatic System and Diseases 3
- Co-authors
- Yu ZhangZhiwen FuShi ChenShijun LiChristopher J. H. PorterNatalie L. TrevaskisLuojuan HuTim Quach
- Journals
- Journal of Pharmaceutical Sciences (7 papers)Molecular Pharmaceutics (6 papers)Journal of Controlled Release (3 papers)Pharmaceutical Research (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- AustraliaChinaNew Zealand
In The Last Decade
Sifei Han
25 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Pharmaceutical Science 257
- Oncology 783
- Radiology, Nuclear Medicine and Imaging 426
- Biomaterials 146
- Immunology 204
Countries citing papers authored by Sifei Han
This map shows the geographic impact of Sifei Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sifei Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sifei Han more than expected).
Fields of papers citing papers by Sifei Han
This network shows the impact of papers produced by Sifei Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sifei Han. The network helps show where Sifei Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Sifei Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | Antibody drug conjugate: the “biological missile” for targeted cancer therapy Hit paper breakdown → | 2022 | 950 |
| 8 | 2021 | 19 | |
| 9 | 2021 | 28 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 26 | |
| 12 | 2020 | 13 | |
| 13 | 2019 | 34 | |
| 14 | 2018 | 46 | |
| 15 | 2017 | 48 | |
| 16 | 2016 | 55 | |
| 17 | 2016 | 28 | |
| 18 | 2016 | 7 | |
| 19 | 2011 | 3 | |
| 20 | 2009 | 74 |
About Sifei Han
Sifei Han is a scholar working on Pharmaceutical Science, Oncology, Transplantation, Gastroenterology and Toxicology, having authored 28 papers that have together received 1.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Drug Solubulity and Delivery Systems (5 papers), Pancreatic function and diabetes (4 papers), Inhalation and Respiratory Drug Delivery (4 papers), Lymphatic System and Diseases (3 papers), Lipid Membrane Structure and Behavior (3 papers), Advanced Drug Delivery Systems (3 papers) and Ion Transport and Channel Regulation (3 papers). The work is most often cited by research in Pharmaceutical Science (257 citations), Oncology (783 citations), Radiology, Nuclear Medicine and Imaging (426 citations), Biomaterials (146 citations) and Immunology (204 citations). Sifei Han has collaborated with scholars based in Australia, China and New Zealand. Frequent co-authors include Yu Zhang, Zhiwen Fu, Shi Chen, Shijun Li, Christopher J. H. Porter, Natalie L. Trevaskis, Luojuan Hu, Tim Quach, Jamie S. Simpson and Suzanne M. Caliph. Their work appears in journals such as Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, Journal of Controlled Release, Pharmaceutical Research and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.